Keywords: EMT; epithelial mesenchymal transition; qRT-PCR; quantitative real time polymerase chain reaction; CXCL12; C-X-C motif chemokine ligand 12; CXCR4; C-X-C chemokine receptor type 4; CK7; cytokeratin-7; CDH1; E-cadherin; CLDN4; claudin-4; HIF-1A; hypoxia ind
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: â¢OH; hydroxyl radical; 2,2-BP; 2,2-bipyridyl; ABC; ATP-binding cassette; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; AMPKK; AMPK kinase; ANT; adenine nucleotide translocase; AP-1; activator protein 1; Apaf-1; protease activating
Keywords: ADAM; a disintegrin and metalloprotease; ADEX; aberrantly differentiated endocrine exocrine; ALDH1; aldehyde dehydrogenase 1; CAFs; cancer associated fibroblasts; CDKN2A; cyclin dependent kinase inhibitor 2A; CSC; cancer stem cell; CTC; circulating tumor
The HACD4 haplotype as a risk factor for atherosclerosis in males
Keywords: CP; carotid plaque; CAD; coronary artery disease; PCR; polymerase chain reaction; MI; myocardial infarction; Athsq1; atherosclerosis susceptibility gene locus 1; PTPLAD2; protein tyrosine phosphatase-like A domain-containing protein; HACD4; 3-hydroxyacyl-
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times
Keywords: Pancreas; Prognosis; Prognostic Factor; Risk; ARID1A; AT-rich interaction domain 1A; ATRX; alpha-thalassemia/mental retardation X-linked; CDKN2A; cyclin dependent kinase inhibitor 2A; DAXX; death domain-associated protein; DFS; disease-free survival; DSS;
E2F6 protein levels modulate drug induced apoptosis in cardiomyocytes
Keywords: α-mhc; α-myosin heavy chain; β2-AR; beta-2-adrenergic receptor; Bax; Bcl2 associated protein X; Bcl2; B-cell lymphoma 2; Blm2; bloom syndrome 2 homolog; Bnip3; Bcl2 interacting protein 3; Chk1; checkpoint kinase 1; c-src; proto-oncogene tyrosine protei
Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression
Keywords: AMPK; AMP - activate kinase alpha 1; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and Rad3-related protein; CHK2; checkpoint kinase 2; CHK1; checkpoint kinase 1; CDK; cyclin-dependent kinase; CDKN2A; cyclin dependent kinase inhibitor 2A;
Prediction of clinical outcomes using the pyrolysis, gas chromatography, and differential mobility spectrometry (Py-GC-DMS) system
Keywords: bcl-1; b-cell lymphoma-isoform 1; CDK4; Cyclin dependent kinase 4; CDKN2A; cyclin dependent kinase inhibitor 2A; MIB-1; mindbomb 1; SOX-11; sry-related HMG box; IL-2Rα; interleukin-2 receptor alpha; IL-8; interleukin-8; MIP-1β; macrophage inflammatory p
Detecting DNA Methylation of the BCL2, CDKN2A and NID2 Genes in Urine Using a Nested Methylation Specific Polymerase Chain Reaction Assay to Predict Bladder Cancer
Keywords: DNA methylation; urinary bladder neoplasms; polymerase chain reaction; ACTB; β-actin; BCL2; B-cell lymphoma 2; CDKN2A; cyclin dependent kinase inhibitor 2A; LMP; low malignancy potential; MSP; methylation specific polymerase chain reaction; NID2; Nidogen